Sequent Scientific Limited to acquire balance stake in Fendigo BV

Consequent to entering into definitive agreement with Mr. Servatius Justinus Cornelius Maria Van Der Heijden for the acquisition of 15% stake from him in Fendigo BV through Alivira Animal Health Limited, Ireland, Wholly Owned Subsidiary of Sequent Scientific Limited. The cost of acquisition will be EUR 191,947.50 (One Hundred Ninety One Thousand Nine Hundred Forty Seven euro and 50 eurocents).

The object of acquisition is to consolidate the Shareholding in Fendigo BV. On completion of the proposed acquisition, Fendigo BV will become a Wholly Owned Subsidiary of the Company.

The said transaction is expected to be completed on or before October 31, 2020.

Fendigo is a veterinary pharmaceutical Company operating in the Benelux region. The Company is involved in sales and marketing of veterinary and health products for pets, farm animals, horses and poultry. By a wide portfolio of products Fendigo responds to the actual needs of veterinarians, farmers and other parties of the Animal Health Sector.

Shares of SEQUENT SCIENTIFIC LTD. was last trading in BSE at Rs.156.15 as compared to the previous close of Rs. 153.75. The total number of shares traded during the day was 108999 in over 2137 trades.

The stock hit an intraday high of Rs. 158.5 and intraday low of 153.85. The net turnover during the day was Rs. 17016954.

Source : Equity Bulls

Keywords